...
首页> 外文期刊>Stem Cell Research & Therapy >A barrier against reactive oxygen species: chitosan/acellular dermal matrix scaffold enhances stem cell retention and improves cutaneous wound healing
【24h】

A barrier against reactive oxygen species: chitosan/acellular dermal matrix scaffold enhances stem cell retention and improves cutaneous wound healing

机译:反应性氧物种的屏障:壳聚糖/无细胞皮肤基质支架增强干细胞保留并改善皮肤伤口愈合

获取原文

摘要

Stem cell therapies have gained great attention for providing novel solutions for treatment of various injuries and diseases due to stem cells’ self-renewal, ability to differentiate into various cell types, and favorite paracrine function. Nevertheless, the low retention of transplanted stem cell still limits their clinical applications such as in wound healing in view of an induced harsh microenvironment rich in reactive oxygen species (ROS) during inflammatory reactions. Herein, a novel chitosan/acellular dermal matrix (CHS/ADM) stem cell delivery system is developed, which is of great ROS scavenging activity and significantly attenuates inflammatory response. Under ROS microenvironment, this stem cell delivery system acts as a barrier, effectively scavenging an amount of ROS and protecting mesenchymal stem cells (MSCs) from the oxidative stress. It notably regulates intracellular ROS level in MSCs and reduces ROS-induced cellular death. Most importantly, such MSCs delivery system significantly enhances in vivo transplanted stem cell retention, promotes the vessel growth, and accelerates wound healing. This novel delivery system, which overcomes the limitations of conventional plain collagen-based delivery system in lacking of ROS-environmental responsive mechanisms, demonstrates a great potential use in stem cell therapies in wound healing.
机译:干细胞疗法对提供了一种新的溶液来治疗各种损伤和疾病,因为干细胞的自我更新,分化为各种细胞类型,以及最喜欢的旁静脉功能。然而,移植干细胞的低保留仍然限制了它们的临床应用,例如伤口愈合,鉴于炎症反应期间富含活性氧物质(ROS)的诱导的刺激性微环境。在此,开发了一种新型壳聚糖/无细胞皮肤基质(CHS / ADM)干细胞递送系统,其是大的ROS清除活性,并且显着衰减炎症反应。在ROS微环境下,该干细胞递送系统用作屏障,有效地清除了从氧化应激中释放的ROS和保护间充质干细胞(MSC)。它显着调节MSC的细胞内ROS水平并降低了ROS诱导的细胞死亡。最重要的是,这种MSCs递送系统显着增强体内移植的干细胞保留,促进血管生长,并加速伤口愈合。这种新型递送系统克服了缺乏ROS环境响应机制缺乏常规普通胶原的递送系统的局限性,证明了在伤口愈合中的干细胞疗法中的潜在用途。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号